ILK-IN-2
ILK-IN-2 (OSU-T315 analog) is an oral PDK2 inhibitor and also an ILK inhibitor, with an IC50 of 0.6 μM. ILK-IN-2 induces cell autophagy and apoptosis, showing anti-tumor activity. ILK-IN-2 directly abolishes AKT activation by preventing AKT from translocating to lipid rafts, triggering Caspase-dependent apoptosis in chronic lymphocytic leukemia (CLL) and extending the lifespan in TCL1 mouse models[1][2].
Product Specifications
CAS Number
1333146-24-9
Product Name Alternative
OSU-T315 analog
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Ser/Thr Kinase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ILK-IN-2.html
Purity
99.41
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(NC)CCC1=NN(C2=CC=C(N3CCNCC3)C=C2)C(C4=CC=C(C5=CC=C(C(F)(F)F)C=C5)C=C4)=C1
Molecular Formula
C30H30F3N5O
Molecular Weight
533.59
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
LPL (Lipoprotein lipase) BioAssayTM ELISA Kit (Rat) discontinued
LPL (Lipoprotein lipase) BioAssayTM ELISA Kit (Rat) discontinued
PTH (Parathyroid Hormone, PTH1) (MaxLight 550)
PTH (Parathyroid Hormone, PTH1) (MaxLight 550)
Human Secreted IL-2 Receptor alpha Recombinant Protein Lyophilized